The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor
Cancer Research, 05/04/2012
Abastado JP – The findings reveal the possibility of developing novel systemic strategies aimed at improving T–cell homing to tumors. Such strategies, used alone or in combination with adoptive T–cell therapies or therapeutic cancer vaccines, may prove to be more efficient in prolonging patient survival.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.